Food and Drug Administration (FDA) in May 2022 to improve glycemic control (on a dietary basis and exercise) in adults with type 2 diabetes and is currently approved in the European Union, Japan and other countries
No peer-reviewed studies have systematically evaluated BPC-157's effects on sexual function or established causality with erectile dysfunction
The compound's gastric-slowing effect peaks 90-120 minutes post-dose and persists for 6-8 hours, so alignment with meal timing is critical
Complementary services at RWA Center that pair well with a Semax protocol include: NAD+ IV therapy cellular energy and mitochondrial support EBOO (extracorporeal blood ozone and oxygenation) systemic oxygenation and immune support TruAge biological age testing epigenetic aging assessment to track longevity progress Blood testing and biomarker analysis baseline and follow-up labs to inform and monitor your protocol Concierge services at-home or private-setting protocols for qualifying patients Table 6: Relevant RWA Center services for Semax patients To schedule a consultation, visit rwacenter.com or call (310) 407-0542
Weight regain patterns The data from similar compounds suggests that most weight lost during treatment is regained within 12 to 18 months of discontinuation
Preclinical studies suggest it promotes the healing of tendons, muscle tissue, and the gastrointestinal tract